Research.Patient.info

B-cell non-Hodgkin lymphoma (NHL) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies
This study is looking at a new medicine called odronextamab for people with a type of blood cancer called B-cell non-Hodgkin lymphoma. It's an early-stage study to see if the medicine is safe and how well people tolerate it.
Germany